€53.00
0.09% yesterday
Xetra, Apr 14, 05:35 pm CET
ISIN
DE000A0LD6E6
Symbol
GXI
Index
Industry

Gerresheimer Stock price

€53.00
-24.00 31.17% 1M
-29.45 35.72% 6M
-18.00 25.35% YTD
-46.00 46.46% 1Y
-14.35 21.31% 3Y
-14.45 21.42% 5Y
-4.20 7.34% 10Y
Xetra, Closing price Mon, Apr 14 2025
-0.05 0.09%
ISIN
DE000A0LD6E6
Symbol
GXI
Index
Industry

Key metrics

Market capitalization €1.83b
Enterprise Value €3.87b
P/E (TTM) P/E ratio 23.26
EV/Sales (TTM) EV/Sales 1.85
P/S ratio (TTM) P/S ratio 0.88
P/B ratio (TTM) P/B ratio 1.21
Dividend yield 2.36%
Last dividend (FY24) €1.25
Revenue growth (TTM) Revenue growth 4.55%
Revenue (TTM) Revenue €2.09b
EBIT (operating result TTM) EBIT €220.60m
Cash position €150.79m
EPS (TTM) EPS €2.28
P/E forward 12.46
P/S forward 0.74
EV/Sales forward 1.56
Show more

Is Gerresheimer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Gerresheimer Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Gerresheimer forecast:

15x Buy
83%
3x Hold
17%

Analyst Opinions

18 Analysts have issued a Gerresheimer forecast:

Buy
83%
Hold
17%

Financial data from Gerresheimer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Feb '25
+/-
%
2,090 2,090
5% 5%
100%
- Direct Costs - -
-
-
605 605
2% 2%
29%
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense 23 23
76% 76%
1%
- -
-
-
- Depreciation and Amortization 212 212
12% 12%
10%
EBIT (Operating Income) EBIT 221 221
7% 7%
11%
Net Profit 79 79
33% 33%
4%

In millions EUR.

Don't miss a Thing! We will send you all news about Gerresheimer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Gerresheimer Stock News

AD HOC NEWS
one day ago
Die US-Bank JPMorgan hat die Einstufung für Gerresheimer DE000A0LD6E6 mit einem Kursziel von 122,50 Euro auf "Overweight" belassen.
AD HOC NEWS
one day ago
Hauck Aufhäuser Investment Banking hat die Einstufung für Gerresheimer DE000A0LD6E6 auf "Buy" mit einem Kursziel von 95 Euro belassen.
AD HOC NEWS
4 days ago
DÜSSELDORF - Der Pharma- und Kosmetik-Verpackungshersteller Gerresheimer DE000A0LD6E6 ist zum Jahresbeginn dank der Übernahme der italienischen Bormioli Pharma kräftig gewachsen.
More Gerresheimer News

Company Profile

Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices; Primary Packaging Glass; and Head Office. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The company was founded on November 3, 2004 and is headquartered in Duesseldorf, Germany.

Head office Germany
CEO Dietmar Siemssen
Employees 12,142
Founded 1864
Website www.gerresheimer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today